Possible link between steatotic liver diseases, severe COVID‑19 and cognitive impairment in post‑COVID‑19 syndrome
Philipp A. Reuken, Freya Wagner, Kathrin Finke, Christina Lemhöfer, Christian Puta, Sven Stengel, André Scherag, Jan‑Christoph Lewejohann, Andreas Stallmach, Stefanie Quickert...
Characteristic immune cell interactions in livers of children with acute hepatitis revealed by spatial single-cell analysis identify a possible postacute sequel of COVID-19
Felix Röttele; Andreas Zollner; Carolin Mogler; Muhammed Yuksel; Cigdem Arikan; Vivien Karl; Judith Helene Aberle; Stephan...
Abstract:
Hepatic encephalopathy, defined as neuropsychiatric dysfunction secondary to liver disease, is a frequent decompensating event in cirrhosis. Its clinical impact is highlighted by a notable increase in patient mortality rates and a concomitant reduction in overall quality of life...
miR-29a-3p, a new myokine orchestrating resistance exercise via coordinated metabolic responses
Paola Pinto-Hernandez; Manuel Fernandez-Sanjurjo; Daan Paget; Xurde M Caravia; David Roiz-Valle; Juan Castilla-Silgado; Sergio Diez-Robles; Almudena Coto-Vilcapoma; Pau Gama; Pablo M Garcia-Roves...
https://www.ncbi.nlm.nih.gov/pubmed/28163011
Obes Res Clin Pract. 2018 Jan - Feb;12(Suppl 2):80-89. doi: 10.1016/j.orcp.2017.01.004. Epub 2017 Feb 3.
Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet...
I decided to start this thread based on the latest findings of the Whole Genome Sequencing webinar from SolveCFS.
During the seminar a slide was shown related to Glycogen Storage Diseases -there are 14 types- and a specific mention was about GSD Type 13 for Enolase beta.
I decided to start...
Hello
Has anyone else any experience of inversion tables? I find them beneficial in a way that I find difficult to explain - general reduction in symptoms and makes me chirpier. I also notice that not using the inversion table seems to have a cumulative bad effect.
I have three vague theories...
https://www.cnbc.com/2018/12/21/the-35-billion-race-for-a-cure-for-a-liver-disease-that-affects-millions.html
(from later in the article my bold)
In spite of the large U.S. patient population at risk, the CDC has not addressed the crisis, and there is no FDA-approved treatment available...
Thought this was interesting, and that I could remember that lipids were of interest to us?
https://www.alz.org/aaic/releases_2018/AAIC18-Tues-gut-liver-brain-axis.asp
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.